Veterinary Medicine Information website

FIPROMEDIC 50 MG SPOT-ON SOLUTION FOR CATS

Authorised
  • Fipronil
Download as PDF

Product identification

Medicine name:
FIPROMEDIC 50 MG SPOT-ON SOLUTION FOR CATS
Active substance:
  • Fipronil
Target species:
  • Cat
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Fipronil
    50.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX15
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:
  • Box of 1 single-dose pipette containing an extractible volume of 0.5 ml
  • Box of 2 single-dose pipettes containing an extractible volume of 0.5 ml
  • Box of 3 single-dose pipettes containing an extractible volume of 0.5 ml
  • Box of 4 single-dose pipettes containing an extractible volume of 0.5 ml
  • Box of 6 single-dose pipettes containing an extractible volume of 0.5 ml
  • Box of 8 single-dose pipettes containing an extractible volume of 0.5 ml
  • Box of 12 single-dose pipettes containing an extractible volume of 0.5 ml
  • Box of 24 single-dose pipettes containing an extractible volume of 0.5 ml
  • Box of 30 single-dose pipettes containing an extractible volume of 0.5 ml
  • Box of 60 single-dose pipettes containing an extractible volume of 0.5 ml
  • Box of 90 single-dose pipettes containing an extractible volume of 0.5 ml
  • Box of 150 single-dose pipettes containing an extractible volume of 0.5 ml
  • Blister box of 1 single-dose pipette containing an extractible volume of 0.5 ml
  • Blister box of 2 single-dose pipettes containing an extractible volume of 0.5 ml
  • Blister box of 3 single-dose pipettes containing an extractible volume of 0.5 ml
  • Blister box of 4 single-dose pipettes containing an extractible volume of 0.5 ml
  • Blister box of 6 single-dose pipettes containing an extractible volume of 0.5 ml
  • Blister box of 8 single-dose pipettes containing an extractible volume of 0.5 ml
  • Blister box of 12 single-dose pipettes containing an extractible volume of 0.5 ml
  • Blister box of 24 single-dose pipettes containing an extractible volume of 0.5 ml
  • Blister box of 30 single-dose pipettes containing an extractible volume of 0.5 ml
  • Blister box of 60 single-dose pipettes containing an extractible volume of 0.5 ml
  • Blister box of 90 single-dose pipettes containing an extractible volume of 0.5 ml
  • Blister box of 150 single-dose pipettes containing an extractible volume of 0.5 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Alfamed
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfamed
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/1525484 5/2009
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0379/001
Concerned member states:
  • Italy
  • Netherlands
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 26/11/2025
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 26/11/2025
Download